Prostate Cancer
Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer - Abstract
September 28, 2012
Enrollment criteria controversies for active surveillance and triggers for conversion to treatment in prostate cancer - Abstract
September 28, 2012
Androgen deprivation therapy: Minimizing exposure and mitigating side effects - Abstract
September 28, 2012
Prescribing of zoledronic acid in a tertiary outpatient hospital setting - Abstract
September 28, 2012
The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample - Abstract
September 28, 2012
Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy - Abstract
September 28, 2012
Providing a fast conversion of total dose to biological effective dose (BED) for hybrid seed brachytherapy - Abstract
September 28, 2012
Talking about sexuality: Desire, virility, and intimacy in the context of prostate cancer associations - Abstract
September 27, 2012
Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer - Abstract
September 27, 2012
Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM) - Abstract
September 27, 2012
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: A prospective study - Abstract
September 27, 2012
Choline intake and risk of lethal prostate cancer: Incidence and survival - Abstract
September 27, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer - Abstract
September 26, 2012
PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35? - Abstract
September 26, 2012
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy - Abstract
September 26, 2012
Cabazitaxel: A novel drug for hormone-refractory prostate cancer - Abstract
September 26, 2012